Activation studies with amino acids and amines of a β-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri previously annotated as Staphylococcus aureus (SauBCA) carbonic anhydrase

References

• (a) Guilloton MB, Korte JJ, Lamblin AF, et al. Carbonic anhydrase in Escherichia coli. A product of the cyn operon. J Biol Chem 1992;267(6):3731–4.
   PubMed Web of Science ®Google Scholar
  (b) Guilloton MB, Lamblin AF, Kozliak EI, et al. A physiological role for cyanate-induced carbonic anhydrase in Escherichia coli. J Bacteriol 1993;175(5):1443–51.
   PubMed Web of Science ®Google Scholar
  (c) Cronk JD, Endrizzi JA, Cronk MR, et al. Crystal structure of E. coli beta-carbonic anhydrase, an enzyme with an unusual pH-dependent activity. Protein Sci 2001;10(5):911–22.
   PubMed Web of Science ®Google Scholar
  (d) Merlin C, Masters M, McAteer S, Coulson A. Why is carbonic anhydrase essential to Escherichia coli? J Bacteriol 2003;185(21):6415–24.
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:34.
   PubMed Web of Science ®Google Scholar
  (f) Di Fiore A, De Luca V, Langella E, et al. Biochemical, structural, and computational studies of a γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei. Comput Struct Biotechnol J 2022;20:4185–94.
   PubMed Web of Science ®Google Scholar
• (a) Urbanski LJ, Bua S, Angeli A, et al. Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase. J Enzyme Inhib Med Chem 2020;35(1):1834–39.
   PubMed Web of Science ®Google Scholar
  (b) Urbanski LJ, Vullo D, Parkkila S, Supuran CT. An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus. J Enzyme Inhib Med Chem 2021;36(1):1088–92.
   PubMed Web of Science ®Google Scholar
• (a) Ferraroni M, Del Prete S, Vullo D, et al. Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Acta Crystallogr D Biol Crystallogr 2015;71(Pt 12):2449–56.
   PubMedGoogle Scholar
  (b) Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23(6):693–704.
   PubMed Web of Science ®Google Scholar
  (c) Nishimori I, Vullo D, Minakuchi T, et al. Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem Lett 2014;24(4):1127–32.
   PubMed Web of Science ®Google Scholar
  (d) Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30(2):325–32.
   PubMed Web of Science ®Google Scholar
• (a) De Luca V, Carginale V, Supuran CT, Capasso C. The gram-negative bacterium Escherichia coli as a model for testing the effect of carbonic anhydrase inhibition on bacterial growth. J Enzyme Inhib Med Chem 2022;37(1):2092–8.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Capasso C. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat 2020;30(12):963–82.
   PubMed Web of Science ®Google Scholar
  (c) Giovannuzzi S, Hewitt CS, Nocentini A, et al. Inhibition studies of bacterial α-carbonic anhydrases with phenols. J Enzyme Inhib Med Chem 2022;37(1):666–71.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018;28(10):745–54.
   PubMed Web of Science ®Google Scholar
  (b) Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem 2021;13(19):1619–22.
   PubMed Web of Science ®Google Scholar
  (c) Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis 2021;7(7):1969–84.
   PubMed Web of Science ®Google Scholar
  (d) Abutaleb NS, Elhassanny AEM, et al. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2022;37(1):51–61.
   PubMed Web of Science ®Google Scholar
  (e) An W, Holly KJ, Nocentini A, et al. Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37(1):1838–44.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7(2):168–81.
   PubMed Web of Science ®Google Scholar
  (b) Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 2019;14(11):1175–97.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31(3):345–60.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12(1):61–88.
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 2016;473(14):2023–32.
   PubMedGoogle Scholar
• (a) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28(10):713–21.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28(10):709–12.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27(12):963–70.
   PubMed Web of Science ®Google Scholar
  (d) Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat 2018;28(10):729–40.
   PubMed Web of Science ®Google Scholar
  (e) Dogné JM, Hanson J, Supuran C, Pratico D. Coxibs and cardiovascular side-effects: from light to shadow. Curr Pharm Des 2006;12(8):971–975.
   PubMed Web of Science ®Google Scholar
• (a) Ozensoy Guler O, Capasso C, Supuran CT. A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzyme Inhib Med Chem 2016;31(5):689–94.
   PubMed Web of Science ®Google Scholar
  (b) De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117–29.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites. 2017;7:E48.
   PubMed Web of Science ®Google Scholar
  (d) Bertol E, Vaiano F, Mari F, et al. Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium. J Enzyme Inhib Med Chem 2017;32(1):841–9.
   PubMed Web of Science ®Google Scholar
  (e) Boztaş M, Çetinkaya Y, Topal M, et al. Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties. J Med Chem 2015;58(2):640–50.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases and metabolism. Metabolites. 2018;8(2):25.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15(6):671–86.
   PubMed Web of Science ®Google Scholar
• (a) Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112(8):4421–68.
   PubMed Web of Science ®Google Scholar
  (b) Briganti F, Pierattelli R, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Part 37. Novel classes of carbonic anhydrase inhibitors and their interaction with the native and cobalt-substituted enzyme: kinetic and spectroscopic investigations. Eur J Med Chem 1996;31(12):1001–10.
   Web of Science ®Google Scholar
  (c) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10(10):767–77.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A. Designing of novel carbonic anhydrase inhibitors and activators. Curr Med Chem Cardiovasc Hematol Agents 2004;2(1):49–68.
   PubMedGoogle Scholar
• (a) Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7(4):56.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018;33(1):485–95.
   PubMed Web of Science ®Google Scholar
  (c) Rahman MM, Tikhomirova A, Modak JK, et al. Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695. Gut Pathog 2020;12:20.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135(10):1233–49.
   PubMed Web of Science ®Google Scholar
• (a) Kumar A, Siwach K, Supuran CT, Sharma PK. A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors. Bioorg Chem 2022;126:105920.
   PubMed Web of Science ®Google Scholar
  (b) Bonardi A, Bua S, Combs J, et al. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. J Enzyme Inhib Med Chem 2022;37(1):930–9.
   PubMed Web of Science ®Google Scholar
  (c) Abdel-Mohsen HT, El Kerdawy AM, Omar MA, et al. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Eur J Med Chem 2022;228:114004.
   PubMed Web of Science ®Google Scholar
  (d) Nocentini A, Angeli A, Carta F, et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36(1):561–80.
   PubMed Web of Science ®Google Scholar
• Briganti F, Mangani S, Orioli P, et al. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36(34):10384–92.
   PubMed Web of Science ®Google Scholar
• (a) Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12(27):7057–66.
   PubMed Web of Science ®Google Scholar
  (b) Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J Med Chem 2006;49(10):3019–27.
   PubMed Web of Science ®Google Scholar
  (c) Temperini C, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV. Bioorg Med Chem 2008;16(18):8373–78.
   PubMed Web of Science ®Google Scholar
  (d) Temperini C, Innocenti A, Scozzafava A, et al. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17(3):628–35.
   PubMed Web of Science ®Google Scholar
• (a) Akocak S, Lolak N, Vullo D, et al. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators. J Enzyme Inhib Med Chem 2017;32(1):1305–12.
   PubMed Web of Science ®Google Scholar
  (b) Akocak S, Lolak N, Bua S, et al. α-Carbonic anhydrases are strongly activated by spinaceamine derivatives. Bioorg Med Chem 2019;27(5):800–4.
   PubMed Web of Science ®Google Scholar
  (c) Akocak S, Lolak N, Bua S, Nocentini A, Supuran CT. Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine Schiff bases and bis-spinaceamine substituted derivatives. J Enzyme Inhib Med Chem 2019;34(1):1193–98.
   PubMed Web of Science ®Google Scholar
  (d) Dave K, Scozzafava A, Vullo D, et al. Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms, I, II and VII. Org Biomol Chem 2011;9(8):2790–800.
   PubMed Web of Science ®Google Scholar
  (e) Dave K, Ilies MA, Scozzafava A, et al. An inhibitor-like binding mode of a carbonic anhydrase activator within the active site of isoform II. Bioorg Med Chem Lett 2011;21(9):2764–68.
   PubMed Web of Science ®Google Scholar
• (a) Bhatt A, Mondal UK, Supuran CT, et al. Crystal structure of carbonic anhydrase II in complex with an activating ligand: implications in neuronal function. Mol Neurobiol 2018;55(9):7431–37.
   PubMed Web of Science ®Google Scholar
  (b) Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I. Bioorg Med Chem Lett 2006;16(19):5152–6.
   PubMed Web of Science ®Google Scholar
  (c) Temperini C, Scozzafava A, Puccetti L, Supuran CT. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15(23):5136–41.
   PubMed Web of Science ®Google Scholar
  (d) Clare BW, Supuran CT. Carbonic anhydrase activators. 3: Structure‐activity correlations for a series of isozyme II activators. J Pharm Sci 1994;83(6):768–73.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrase activators. Future Med Chem. 2018;10(5):561–73.
   PubMed Web of Science ®Google Scholar
  (b) Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase activation and the drug design. Curr Pharm Des 2008;14(7):708–15.
   PubMed Web of Science ®Google Scholar
  (c) Akocak S, Supuran CT. Activation of α-, β-, γ- δ-, ζ- and η- class of carbonic anhydrases with amines and amino acids: a review. J Enzyme Inhib Med Chem 2019;34(1):1652–1659.
   PubMed Web of Science ®Google Scholar
  (d) Angeli A, Vaiano F, Mari F, et al. Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII. J Enzyme Inhib Med Chem 2017;32(1):1253–1259.
   PubMed Web of Science ®Google Scholar
• (a) Canto de Souza L, Provensi G, Vullo D, et al. Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. Neuropharmacology 2017;118:148–56.
   PubMed Web of Science ®Google Scholar
  (b) Sanku RKK, John JS, Salkovitz M, et al. Potential learning and memory disruptors and enhancers in a simple, 1-day operant task in mice. Behav Pharmacol 2018;29(6):482–92.
   PubMed Web of Science ®Google Scholar
  (c) Schmidt SD, Nachtigall EG, Marcondes LA, et al. Modulation of carbonic anhydrases activity in the hippocampus or prefrontal cortex differentially affects social recognition memory in rats. Neuroscience. 2022;497:184–95.
   PubMed Web of Science ®Google Scholar
  (d) Provensi G, Nocentini A, Passani MB, et al. Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives. J Enzyme Inhib Med Chem 2021;36(1):719–26.
   PubMed Web of Science ®Google Scholar
  (e) Schmidt SD, Costa A, Rani B, et al. The role of carbonic anhydrases in extinction of contextual fear memory. Proc Natl Acad Sci USA 2020;117(27):16000–8.
   PubMed Web of Science ®Google Scholar
  (f) Blandina P, Provensi G, Passsani MB, et al. Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders. J Enzyme Inhib Med Chem 2020;35(1):1206–14.
   PubMed Web of Science ®Google Scholar
• (a) Innocenti A, Zimmerman SA, Scozzafava A, et al. Carbonic anhydrase activators: activation of the archaeal β-class (Cab) and γ-class (Cam) carbonic anhydrases with amino acids and amines. Bioorg Med Chem Lett 2008;18(23):6194–8.
   PubMed Web of Science ®Google Scholar
  (b) Vullo D, Del Prete S, Capasso C, Supuran CT. Carbonic anhydrase activators: activation of the β-carbonic anhydrase from Malassezia globosa with amino acids and amines. Bioorg Med Chem Lett 2016;26(5):1381–85.
   PubMed Web of Science ®Google Scholar
  (c) Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase activators: activation of the β-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amino acids and amines. Bioorg Med Chem Lett 2009;19(6):1662–5.
   PubMed Web of Science ®Google Scholar
  (d) Innocenti A, Hall RA, Scozzafava A, et al. Carbonic anhydrase activators: activation of the beta-carbonic anhydrases from the pathogenic fungi Candida albicans and Cryptococcus neoformans with amines and amino acids. Bioorg Med Chem 2010;18(3):1034–7.
   PubMed Web of Science ®Google Scholar
• (a) Angeli A, Del Prete S, Osman SM, et al. Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids. J Enzyme Inhib Med Chem 2018;33(1):227–33.
   PubMed Web of Science ®Google Scholar
  (b) Angeli A, Del Prete S, Donald WA, et al. The γ-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae is potently activated by amines and amino acids. Bioorg Chem 2018;77:1–5.
   PubMed Web of Science ®Google Scholar
  (c) Angeli A, Del Prete S, Osman SM, et al. Activation studies with amines and amino acids of the β-carbonic anhydrase encoded by the Rv3273 gene from the pathogenic bacterium Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2018;33(1):364–69.
   PubMed Web of Science ®Google Scholar
• (a) Angeli A, Del Prete S, Pinteala M, et al. The first activation study of the β-carbonic anhydrases from the pathogenic bacteria Brucella suis and Francisella tularensis with amines and amino acids. J Enzyme Inhib Med Chem 2019;34(1):1178–85.
   PubMed Web of Science ®Google Scholar
  (b) Stefanucci A, Angeli A, Dimmito MP, et al. Activation of β- and γ-carbonic anhydrases from pathogenic bacteria with tripeptides. J Enzyme Inhib Med Chem 2018;33(1):945–50.
   PubMed Web of Science ®Google Scholar
  (c) Nocentini A, Del Prete S, Mastrolorenzo MD, et al. Activation studies of the β-carbonic anhydrases from Escherichia coli with amino acids and amines. J Enzyme Inhib Med Chem 2020;35(1):1379–86.
   PubMed Web of Science ®Google Scholar
• (a) Gramoli JL, Wilkinson BJ. Characterization and identification of coagulase-negative, heat-stable deoxyribonuclease-positive staphylococci. J Gen Microbiol 1978;105(2):275–285.
   PubMedGoogle Scholar
  (b) Fungwithaya P, Boonchuay K, Narinthorn R, et al. First study on diversity and antimicrobial-resistant profile of staphylococci in sports animals of Southern Thailand. Vet World 2022;15(3):765–74.
   PubMed Web of Science ®Google Scholar
  (c) Cai Y, Zheng L, Lu Y, et al. Inducible resistance to β-lactams in oxacillin-susceptible mecA1-positive Staphylococcus sciuri isolated from retail pork. Front Microbiol 2021;12:721426.
   PubMed Web of Science ®Google Scholar
  (d) Chen S, Wang Y, Chen F, et al. A highly pathogenic strain of Staphylococcus sciuri caused fatal exudative epidermitis in piglets. PLoS One 2007;2(1):e147.
   PubMed Web of Science ®Google Scholar
• Madhaiyan M, Wirth JS, Saravanan VS. Phylogenomic analyses of the Staphylococcaceae family suggest the reclassification of five species within the genus Staphylococcus as heterotypic synonyms, the promotion of five subspecies to novel species, the taxonomic reassignment of five Staphylococcus species to Mammaliicoccus gen. nov., and the formal assignment of Nosocomiicoccus to the family Staphylococcaceae. Int J Syst Evol Microbiol. 2020;70(11):5926–5936.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• (a) Fan S-H, Matsuo M, Huang L, et al. The MpsAB bicarbonate transporter is superior to carbonic anhydrase in biofilm-forming bacteria with limited CO2 diffusion. Microbiol Spectr 2021;9(1):e0030521.
   PubMed Web of Science ®Google Scholar
  (b) Fan SH, Liberini E, Götz F. Staphylococcus aureus genomes harbor only MpsAB-like bicarbonate transporter but not carbonic anhydrase as dissolved inorganic carbon supply system. Microbiol Spectr 2021;9(3):e0097021.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Briganti F. Carbonic anhydrase inhibitors: N-cyanosulfonamides, a new class of high affinity isozyme II and IV inhibitors. J Enzyme Inhib. 1999;14(4):289–306.
   PubMed Web of Science ®Google Scholar
• (a) Amedei A, Capasso C, Nannini G, Supuran CT. Microbiota, bacterial carbonic anhydrases, and modulators of their activity: links to human diseases? Mediators Inflamm 2021;2021:6926082.
   PubMedGoogle Scholar
  (b) Nocentini A, Supuran CT, Capasso C. An overview on the recently discovered iota-carbonic anhydrases. J Enzyme Inhib Med Chem 2021;36(1):1988–95.
   PubMed Web of Science ®Google Scholar
  (c) Campestre C, De Luca V, Carradori S, et al. Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori. Front Microbiol 2021;12:629163.
   PubMed Web of Science ®Google Scholar
  (d) Del Prete S, Nocentini A, Supuran CT, Capasso C. Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2020;35(1):1060–8.
   PubMed Web of Science ®Google Scholar